Abstract

Objective

The ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE study in Japan (OVERCOME [Japan]) aimed to provide an up-to-date assessment of migraine epidemiology in Japan.

Methods

OVERCOME (Japan) was a cross-sectional, population-based web survey of Japanese adults recruited from consumer panels. People with active migraine (met modified International Classification of Headache Disorders, 3rd edition [ICHD-3] criteria or had a self-reported physician diagnosis of migraine) answered questions about headache features, physician consultation patterns, and migraine medication use. The burden and impact of migraine were assessed using Migraine Disability Assessment (MIDAS) and Work Productivity and Activity Impairment scales.

Results

In total, 231,747 respondents accessed the screener, provided consent, and were eligible for the survey. The migraine group included 17,071 respondents (mean ± SD age 40.7 ± 13.0 years; 66.5% female). ICHD-3 migraine criteria were met by 14,033 (82.2%) respondents; 9667 (56.6%) self-reported a physician diagnosis of migraine. The mean number of monthly headache days was 4.5 ± 5.7 and pain severity (0–10 scale) was 5.1 ± 2.2. In the migraine group, 20.7% experienced moderate to severe migraine-related disability (MIDAS score ≥ 11). Work productivity loss was 36.2% of work time missed, including 34.3% presenteeism. Only 57.4% of respondents had ever sought medical care for migraine/severe headache. Most respondents (75.2%) were currently using over-the-counter medications for migraine; 36.7% were using prescription nonsteroidal anti-inflammatory drugs, and only 14.8% were using triptans. Very few (9.2%) used preventive medications.

Conclusions

Unmet needs for migraine health care among people with migraine in Japan include low rates of seeking care and suboptimal treatment.

中文翻译：

---

日本基于人群的偏头痛综合调查：偏头痛流行病学、治疗和护理观察性调查（OVERCOME [日本]）研究的结果

摘要

客观的

日本偏头痛流行病学、治疗和护理研究 (OVERCOME [日本]) 的观察性调查旨在提供日本偏头痛流行病学的最新评估。

方法

OVERCOME（日本）是一项基于人口的横断面网络调查，调查对象是从消费者小组中招募的日本成年人。患有活动性偏头痛（符合修订的国际头痛疾病分类，第 3 版 [ICHD-3] 标准或有医生自我报告偏头痛诊断）的人回答了有关头痛特征、医生咨询模式和偏头痛药物使用的问题。偏头痛的负担和影响使用偏头痛残疾评估 (MIDAS) 和工作生产力和活动障碍量表进行评估。

结果

总共有 231,747 名受访者访问了筛选器，同意并有资格参加调查。偏头痛组包括 17,071 名受访者（平均 ± SD 年龄 40.7 ± 13.0 岁；66.5% 女性）。14,033 (82.2%) 名受访者符合 ICHD-3 偏头痛标准；9667 (56.6%) 自我报告了偏头痛的医生诊断。每月平均头痛天数为 4.5 ± 5.7，疼痛严重程度（0-10 级）为 5.1 ± 2.2。在偏头痛组中，20.7% 的患者出现中度至重度偏头痛相关残疾（MIDAS 评分 ≥ 11）。工作效率损失为 36.2% 的工作时间错过，包括 34.3% 的出勤率。只有 57.4% 的受访者曾因偏头痛/严重头痛而寻求医疗护理。大多数受访者 (75.2%) 目前正在使用非处方药治疗偏头痛；36. 7% 使用处方非甾体抗炎药，只有 14.8% 使用曲坦类药物。很少（9.2%）使用预防性药物。

结论

日本偏头痛患者对偏头痛医疗保健的需求未得到满足，包括寻求护理率低和治疗效果不佳。